VIA
Vident Investment Advisory’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-587,011
| Closed | -$477K | – | 915 |
|
|
2018
Q1 | $477K | Buy |
587,011
+159,433
| +37% | +$130K | 0.02% | 628 |
|
|
2017
Q4 | $1.21M | Sell |
427,578
-67,440
| -14% | -$191K | 0.05% | 350 |
|
|
2017
Q3 | $1.42M | Buy |
495,018
+15,000
| +3% | +$42.9K | 0.08% | 321 |
|
|
2017
Q2 | $1.19M | Buy |
480,018
+243,963
| +103% | +$603K | 0.1% | 304 |
|
|
2017
Q1 | $852K | Buy |
236,055
+39,340
| +20% | +$142K | 0.08% | 318 |
|
|
2016
Q4 | $696K | Buy |
196,715
+43,128
| +28% | +$153K | 0.08% | 313 |
|
|
2016
Q3 | $620K | Buy |
153,587
+2,944
| +2% | +$11.9K | 0.08% | 321 |
|
|
2016
Q2 | $661K | Buy |
150,643
+57,949
| +63% | +$254K | 0.09% | 337 |
|
|
2016
Q1 | $350 | Buy |
92,694
+43,258
| +88% | +$163 | 0.02% | 367 |
|
|
2015
Q4 | $775K | Buy |
+49,436
| New | +$775K | 0.1% | 336 |
|